• 1. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 2. Always a matter of interpretation: inferring student knowledge and understanding from research data
  Chem. Educ. Res. Pract., 2017,18, 7-12
• 3. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
• 4. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 5. An AuNPs-functionalized AlGaN/GaN high electron mobility transistor sensor for ultrasensitive detection of TNT?
  Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Comprehensive Overview of 6-(Benzyloxy)-4-methylpyridin-3-amine (CAS No. 1503044-76-5): Properties, Applications, and Industry Insights

6-(Benzyloxy)-4-methylpyridin-3-amine (CAS No. 1503044-76-5) is a specialized organic compound that has garnered significant attention in pharmaceutical and agrochemical research. This pyridine derivative, characterized by its benzyloxy and methylamine functional groups, serves as a versatile intermediate in synthetic chemistry. Its molecular structure (C₁₃H₁₄N₂O) enables unique reactivity patterns, making it valuable for constructing complex heterocyclic frameworks. Recent studies highlight its role in developing kinase inhibitors and antimicrobial agents, aligning with the growing demand for targeted therapies in precision medicine.

The compound's physicochemical properties—including a molecular weight of 214.26 g/mol and moderate lipophilicity (LogP ~2.1)—make it particularly suitable for drug discovery applications. Researchers frequently employ 6-(Benzyloxy)-4-methylpyridin-3-amine as a building block for structure-activity relationship (SAR) studies, especially in optimizing bioavailability and blood-brain barrier penetration. Industry reports indicate a 23% annual growth in demand for such functionalized pyridines, driven by their utility in developing next-generation small molecule drugs.

From a synthetic perspective, this compound exemplifies modern green chemistry principles. Recent patents (e.g., WO2022155567) describe improved catalytic methods for its production using palladium-catalyzed cross-coupling reactions, achieving yields exceeding 85% with reduced environmental impact. Such advancements address the pharmaceutical industry's push toward sustainable API manufacturing, a topic generating over 12,000 monthly searches in scientific databases.

Analytical characterization of CAS 1503044-76-5 typically involves HPLC purity analysis (>98%), mass spectrometry, and NMR spectroscopy. The compound's stability profile—stable under inert atmospheres up to 180°C—makes it suitable for high-temperature reactions, a feature frequently queried in chemical forums. Notably, its benzyl-protected amine group allows selective deprotection strategies, enabling sequential functionalization—a technique discussed in over 300 recent PubMed-indexed articles.

Emerging applications include its use in fluorescent probes for cellular imaging, leveraging the pyridine core's electron-rich properties. This aligns with the booming diagnostics market, projected to reach $84 billion by 2027. Additionally, computational studies (J. Med. Chem. 2023, 66, 5122) suggest potential in allosteric modulator design, particularly for G-protein coupled receptors (GPCRs)—a hot topic with 8,500+ monthly academic searches.

Quality control protocols for 6-(Benzyloxy)-4-methylpyridin-3-amine emphasize residual solvent analysis (meeting ICH Q3C guidelines) and chiral purity verification, reflecting industry standards for GMP intermediates. Suppliers increasingly provide custom synthesis services for derivatives, responding to the trend of fragment-based drug discovery (search volume up 40% YoY). The compound's SCAS registry number ensures proper tracking in global supply chains, crucial for REACH compliance.

Future research directions may explore its metal-organic framework (MOF) applications or photocatalytic properties, areas generating substantial academic interest. With 17 patent filings referencing this structure since 2021, 1503044-76-5 remains at the forefront of medicinal chemistry innovation, offering solutions to challenges in drug resistance and selective targeting—topics dominating recent conference proceedings (ACS Spring 2024).

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)